Recently, Jvion had the distinction of being included in AI Time Journal’s list of the Top 25 AI Companies of 2019. The list highlights the contributions of organizations proactively applying artificial intelligence and machine learning to solve complex problems for the benefit of humanity. It has been a momentous year for Jvion, and it is an honor to be recognized for the work we’ve done to prevent harm and lower healthcare costs. As we look forward to 2020, let’s take a look back at some of our biggest accomplishments from 2019.
More Hospitals, More Harm Prevented
This year, multiple hospitals and health systems announced they would begin or continue using Jvion to help prevent patient harm. This is always our favorite news to share, because it means more patient lives are being protected and saved.
In January, Northwell Health announced it would integrate the Jvion CORE into the electronic medical records (EMR) at 15 of the health system’s hospitals, targeting readmissions and avoidable admissions within its managed care population. Mercy Medical Center in Canton, Ohio also announced that it lowered readmission rates by more than 20 percent after implementing the Jvion Machine.
Sentara Health’s use of the Jvion CORE to prevent sepsis was profiled in August in the Virginian-Pilot, and in September, Novant Health announced it would be partnering with Jvion for its new institute of innovation and artificial intelligence.
It’s been an exciting year as Jvion has stepped into the spotlight and gained increased levels of recognition for the work we do to prevent patient harm.
In April, Jvion’s technologies were featured in both the Journal of Clinical Pathways for Oncology Care and the 2013-2028 Report on Global Machine Learning in Medicine Market by Player, Region, Type and Application report; in August, an article in the American Journal of Managed Care (AJMC) showcased Jvion’s impact on delivering efficient cancer care.
In October, Jvion was recognized as one of the CB Insights Digital Health 150 for its innovative use of AI, and in November, Jvion was identified as a top performer in AI-healthcare by KLAS with highest number of clients and clinical use cases in the market.
Investment and Growth
Jvion kicked off the new year with good news on January 3, announcing that it raised a significant growth equity investment led by JMI Equity (JMI), a growth equity firm focused on investing in leading software companies. Additional investors included Health Enterprise Partners (HEP) and Health Velocity Capital (HVC), two leading healthcare investment firms whose limited partner networks comprise some of the largest hospital systems and health plans in the country.
Later in the year, additional growth investment was announced from healthcare leaders Intermountain Healthcare and Trinity Health. This round of funding is an expansion of the existing customer relationship between Jvion and both providers, and demonstrates their respective ongoing commitments to healthcare innovation, including the practical application of AI solutions for driving improved quality and health outcomes.
Continued Commitment to Client Success
2019 was also marked by continued investment and expansion of our client success program. In addition to the onboarding of our new Senior Vice President of Customer Success, we expanded our team of clinical adoption specialists, refined our ROI reporting processes, and continued to develop best of breed resources to accelerate the successful implementation of purpose-built AI. These activities will continue to broaden and become more mature through 2020 and beyond.
The past year has been an exciting one at Jvion, and we look forward to reaching even more patients and healthcare systems in 2020!